Lung transplantation Clinical Trials

20 recruitingLast updated: June 18, 2026

There are 20 actively recruiting lung transplantation clinical trials across 13 countries. Studies span Not Applicable, Phase 2. Top locations include Jacksonville, Florida, United States, San Francisco, California, United States, Philadelphia, Pennsylvania, United States. Updated daily from ClinicalTrials.gov.


Lung transplantation Trials at a Glance

20 actively recruiting trials for lung transplantation are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Jacksonville, San Francisco, and Philadelphia. Lead sponsors running lung transplantation studies include University of Pennsylvania, Mayo Clinic, and Chiesi España, S.A.U..

Browse lung transplantation trials by phase

Treatments under study

About Lung transplantation Clinical Trials

Looking for clinical trials for Lung transplantation? There are currently 19 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lung transplantation trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lung transplantation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 20 trials

Recruiting

Trifecta-Lung cfDNA-MMDx Study

Lung transplantation
University of Alberta600 enrolled19 locationsNCT05837663
Recruiting
Phase 2

LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.

Bronchiolitis Obliterans SyndromeLung transplantationChronic lung allograft dysfunction
Steven Hays, MD30 enrolled1 locationNCT06018766
Recruiting
Not Applicable

Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients

Post-Lung Transplantation Bronchiectasis
Mayo Clinic90 enrolled1 locationNCT04582279
Recruiting
Phase 2

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

Acute Lung Injury(ALI)Natural Killer Cell Mediated ImmunityPrimary Graft Dysfunction+1 more
University of California, San Francisco120 enrolled1 locationNCT06853223
Recruiting
Not Applicable

Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant

Post-Lung Transplantation Bronchiectasis
Mayo Clinic30 enrolled1 locationNCT04783155
Recruiting

Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation

Quality of LifePregnancyKidney Transplant+10 more
University Medical Center Groningen200 enrolled1 locationNCT07291258
Recruiting

Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation

Primary Graft DysfunctionLung transplantation
University of Pennsylvania1,150 enrolled1 locationNCT00552357
Recruiting

Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation

Primary Graft DysfunctionLung transplantation
University of Pennsylvania1,150 enrolled1 locationNCT00457847
Recruiting
Not Applicable

Lung Transplant Candidates: Effects of Aerobic vs. HIIT Training on ICF Assessments

Lung transplantation
Ankara City Hospital Bilkent34 enrolled1 locationNCT07065318
Recruiting
Not Applicable

Electrical Activity of the Diaphragm and Respiratory Mechanics During NAVA

ventilator-induced lung injuryWork of BreathingAcute Respiratory Failure (ARF)+2 more
University of Padova40 enrolled1 locationNCT05689476
Recruiting

Study of Tacrolimus Melt-Dose® for Lung Transplant Patients

Lung TrasplantLung transplantation
Chiesi España, S.A.U.240 enrolled2 locationsNCT07042035
Recruiting

Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation

Extracorporeal Membrane Oxygenation (ECMO)Anticoagulants and Bleeding DisordersLung transplantation
University Hospital, Motol40 enrolled1 locationNCT06868823
Recruiting
Not Applicable

Transplanting Lungs From Uncontrolled Donation After Circulatory Death

Lung transplantation
NYU Langone Health24 enrolled1 locationNCT06327945
Recruiting

A study testing whether use of a commercially available continuous glucose monitoring device is as effective as traditional blood tests for diagnosis of diabetes in heart or lung transplant recipients thought to be free from diabetes at least 1-year after transplant surgery.

Post transplant diabetes mellitusLung transplantation
St Vincent's Hospital Sydney100 enrolled1 locationACTRN12625000209493
Recruiting
Not Applicable

Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)

Heart TransplantationCytomegalovirus InfectionsLiver Transplantation+2 more
University Hospital, Grenoble288 enrolled1 locationNCT06341543
Recruiting

The Effect of Perioperative Factors on Postoperative Outcomes After Lung Transplantation

Postoperative Complications After Lung Transplantation
Second Affiliated Hospital, School of Medicine, Zhejiang University200 enrolled1 locationNCT06603350
Recruiting

Sleep-disordered Breathing After Solid Organ Transplantation

Sleep-Disordered BreathingLung transplantation
Universitaire Ziekenhuizen KU Leuven300 enrolled1 locationNCT03142022
Recruiting

Pain Relief for Lung Transplantation

Lung transplantation
St Vincent’s Public Hospital Sydney48 enrolled1 locationACTRN12624000714583
Recruiting

Conversion lung transplant patients from Prograf to Advagraf or Envarsus

for patient with lung transplantation
University Hospital Motol50 enrolled1 locationACTRN12622000664741
Recruiting

Upper limb rehabilitation following lung transplantation

Upper limb pain, movement and strength after lung transplantation
The Alfred80 enrolled1 locationACTRN12613000941763